Meningococcal Group B Vaccine (Bexsero) is indicated for active immunisation of individuals from 2 months of age and older against invasive meningococcal disease caused by Neisseria meningitidis group B (see Pharmacology: Pharmacodynamics: Pharmacodynamic effects under Actions for information on protection against specific group B strains).
The use of Meningococcal Group B Vaccine (Bexsero) should be in accordance with official recommendations.
                                
                            Other Services
                            
                            
                            Country
                            Account
                            
                         
 
            
 
         
                 
                                     
                             
                                             
                                             Sign Out
 Sign Out
                                     
                                             
                                             
                                            